Status:
COMPLETED
Real-life Clinical Experience With Ialuadapter Study
Lead Sponsor:
Radboud University Medical Center
Conditions:
Interstitial Cystitis, Chronic
Overactive Bladder Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective study from a single center was performed. Quantitative and qualitative data was obtained on the use of the syringe adapter (IALUADAPTER®) in 61 patients with IC/BPS (n=48), rUTI (n=6) ...
Detailed Description
Introduction Intravesical treatment is currently dependent on catheterization which can cause urethral discomfort and risk of urinary tract infections in selected patient groups such as interstitial c...
Eligibility Criteria
Inclusion
- Patients with IC/BPS, recurrent UTIs and/or OAB
- Receiving intravesical instillations with a conventional single-use catheter before the syringe adapter evaluation period which took place between September 2018 and the end of February 2019 (6m).
Exclusion
- Patients with a high post-void residue of \>100ml or with an indwelling catheter were excluded from the analyses.
- Patients who cannot sign informed consent.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT06540248
Start Date
November 1 2023
End Date
November 30 2023
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 HB